Experience: Track record 2002-2008

• Therapeutic areas
• Study sites
• Submission dossiers

Therapeutic areas

The track record of our associates over the past years is impressive. Numerous studies in the following therapeutic areas:

Allergology Anti-Infectives Cardiology Dermatology Hematology Immunology Inflammation and Rheumatology

Metabolism and Diabetes Neurology and Psychiatry Oncology Pain Pediatric Medicine Plasma Proteins Vaccines

Study sites

Over 3,000 study sites covered, involving:

• 2,000 investigators
• 31,000 subjects
• over 20 countries

Submission dossiers

Over 20 successful regulatory submission dossiers for USA and Europe, including:

• Altace® /Delix® (heart failure)
• Altace® /Delix® (hypertension with high cardiovascular risk)
• Altace® /Delix® (renoprotection in hypertension)
• Amaryl® (diabetes)
• Arava® (rheumatoid arthritis)
• Penlac® nail lacquer (onychomycosis)
• Delmuno® (hypertension)
• Dynepo® (anemia in chronic renal failure)
• Insuman® (diabetes)
• Ketek® (bacterial infections)
• Lantus® (diabetes)
• Loprox® /Batrafen® shampoo (serborrhoeic dermatitis)
• Profact® (endometriosis)
• Profact® (leiomyoma)
• Profact® (prostate cancer)
• Tavanic® (bacterial infections)
• Tavanic® (severe bacterial infections)